N
Neurocrine Biosciences
NBIX
153.020
USD
11.66
(8.25%)
مغلق
حجم التداول
24,149
الربح لكل سهم
0
العائد الربحي
0
P/E
35
حجم السوق
11,790,996,596
الأخبار
العنوان: Neurocrine Biosciences
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.